Upgrade to SI Premium - Free Trial

Vertex Pharma (VRTX)

447.24 +5.50 (1.25%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 4 VERTEX PHARMACEUTICALS For: Jun 01 Filed by: Liu Joy June 3, 2026 4:07 PM - SEC Filing Vertex to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 10 June 3, 2026 4:00 PM - BizWire Form 4 VERTEX PHARMACEUTICALS For: May 29 Filed by: Bozic Carmen June 2, 2026 4:04 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Liu Joy June 1, 2026 2:14 PM - SEC Filing Vertex gets FDA acceptance for IgA nephropathy drug application June 1, 2026 8:01 AM - StreetInsider Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy June 1, 2026 8:00 AM - BizWire Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen May 29, 2026 1:32 PM - SEC Filing JPMorgan says large-cap biotech is back as profits and pipelines fuel upside May 28, 2026 4:07 PM - StreetInsider Truist Securities Assumes Vertex (VRTX) at Buy May 27, 2026 1:02 AM - StreetInsider JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms May 20, 2026 3:10 PM - StreetInsider JPMorgan Reinstates Vertex (VRTX) at Overweight May 20, 2026 4:30 AM - StreetInsider Form 4 VERTEX PHARMACEUTICALS For: May 15 Filed by: Bunnage Mark E. May 19, 2026 4:05 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 15 Filed by: Bozic Carmen May 19, 2026 4:04 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen May 15, 2026 10:41 AM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Bunnage Mark E. May 15, 2026 10:02 AM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 12 Filed by: Bozic Carmen May 14, 2026 4:10 PM - SEC Filing Form SCHEDULE 13G/A VERTEX PHARMACEUTICALS Filed by: Capital World Investors May 14, 2026 1:56 PM - SEC Filing Form SCHEDULE 13G/A VERTEX PHARMACEUTICALS Filed by: Capital Research Global Investors May 14, 2026 10:20 AM - SEC Filing Form S-8 POS VERTEX PHARMACEUTICALS May 13, 2026 4:11 PM - SEC Filing Form S-8 POS VERTEX PHARMACEUTICALS May 13, 2026 4:10 PM - SEC Filing Form S-8 POS VERTEX PHARMACEUTICALS May 13, 2026 4:10 PM - SEC Filing Form S-8 POS VERTEX PHARMACEUTICALS May 13, 2026 4:10 PM - SEC Filing Form S-8 POS VERTEX PHARMACEUTICALS May 13, 2026 4:10 PM - SEC Filing Form S-8 POS VERTEX PHARMACEUTICALS May 13, 2026 4:10 PM - SEC Filing Form S-8 POS VERTEX PHARMACEUTICALS May 13, 2026 4:10 PM - SEC Filing Form S-8 VERTEX PHARMACEUTICALS May 13, 2026 4:08 PM - SEC Filing Form 8-K VERTEX PHARMACEUTICALS For: May 13 May 13, 2026 4:03 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen May 12, 2026 1:12 PM - SEC Filing Vertex to Participate in Upcoming May Investor Conferences May 11, 2026 4:00 PM - BizWire BMO Capital Reiterates Market Perform Rating on Vertex (VRTX), 'positive steps' May 8, 2026 8:59 AM - StreetInsider Form 144 VERTEX PHARMACEUTICALS Filed by: Biller Jonathan May 6, 2026 2:14 PM - SEC Filing Vertex (VRTX) PT Raised to $615 at Barclays May 6, 2026 7:04 AM - StreetInsider Vertex secures German reimbursement for CASGEVY gene therapy May 6, 2026 7:01 AM - StreetInsider Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany May 6, 2026 7:01 AM - BizWire Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Upadhyay Suketu May 5, 2026 5:44 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Thornberry Nancy May 5, 2026 5:38 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Schneider Jennifer May 5, 2026 5:30 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: SACHS BRUCE I May 5, 2026 5:25 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: MCKENZIE DIANA May 5, 2026 5:18 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Liu Joy May 5, 2026 5:11 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Lagarde Michel May 5, 2026 5:07 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Garber Alan M May 5, 2026 4:59 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: CARNEY LLOYD May 5, 2026 4:54 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: May 01 Filed by: Bhatia Sangeeta N. May 5, 2026 4:51 PM - SEC Filing Form 10-Q VERTEX PHARMACEUTICALS For: Mar 31 May 5, 2026 4:10 PM - SEC Filing Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX) Post Q1 Print May 5, 2026 9:26 AM - StreetInsider Vertex (VRTX) PT Raised to $616 at Morgan Stanley May 5, 2026 8:01 AM - StreetInsider Vertex (VRTX) PT Lowered to $436 at Canaccord May 5, 2026 7:06 AM - StreetInsider Vertex (VRTX) PT Raised to $543 at RBC Capital May 5, 2026 6:36 AM - StreetInsider Oppenheimer Reiterates Outperform Rating on Vertex (VRTX) May 5, 2026 6:06 AM - StreetInsider Vertex (VRTX) PT Lowered to $572 at Bernstein SocGen Group May 5, 2026 5:59 AM - StreetInsider Form 8-K VERTEX PHARMACEUTICALS For: May 04 May 4, 2026 4:06 PM - SEC Filing Vertex Pharma (VRTX) Tops Q1 EPS by 14c, Misses on Revenue; Offers FY26 Revenue Guidance May 4, 2026 4:03 PM - StreetInsider Vertex Reports First Quarter 2026 Financial Results May 4, 2026 4:01 PM - BizWire Form 144 VERTEX PHARMACEUTICALS Filed by: Bhatia Sangeeta N. May 4, 2026 10:18 AM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Liu Joy May 1, 2026 2:29 PM - SEC Filing Form SCHEDULE 13G VERTEX PHARMACEUTICALS Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 30, 2026 2:30 PM - SEC Filing Vortex Energy Announces Intent to Advance Next Phase of Technical Work at the Robinsons River Salt Project and Engages Lonquist April 30, 2026 8:00 AM - Globe NewsWire Vertex (VRTX) PT Lowered to $437 at Canaccord April 30, 2026 6:35 AM - StreetInsider Form DEFA14A VERTEX PHARMACEUTICALS April 29, 2026 4:08 PM - SEC Filing Form 8-K VERTEX PHARMACEUTICALS For: Apr 28 April 29, 2026 4:05 PM - SEC Filing U.S. Biotech stocks: Q1 earnings previews April 26, 2026 8:00 PM - StreetInsider Vertex (VRTX) PT Lowered to $14 at BMO Capital April 24, 2026 8:32 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX) April 23, 2026 6:58 AM - StreetInsider These are the best biotech stocks to own in 2026: BofA April 19, 2026 10:00 AM - StreetInsider Form 4 VERTEX PHARMACEUTICALS For: Apr 15 Filed by: Upadhyay Suketu April 17, 2026 4:21 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Apr 15 Filed by: SACHS BRUCE I April 17, 2026 4:18 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Apr 15 Filed by: Garber Alan M April 17, 2026 4:15 PM - SEC Filing Zealand Pharma names Eric Rojas as VP of investor relations April 14, 2026 10:01 AM - StreetInsider Zealand Pharma names Eric Rojas as VP of investor relations April 14, 2026 10:00 AM - StreetInsider Bernstein on US Pharma and Biotech: Who might buy whom? April 13, 2026 5:52 AM - StreetInsider Vertex (VRTX) PT Lowered to $541 at RBC Capital April 10, 2026 8:33 AM - StreetInsider Vertex (VRTX) PT Raised to $612 at Morgan Stanley April 10, 2026 8:16 AM - StreetInsider Vertex (VRTX) PT Raised to $543 at RBC Capital April 7, 2026 9:03 AM - StreetInsider Halozyme licenses drug delivery technology to Vertex for $15 million April 7, 2026 8:05 AM - StreetInsider Vertex to Announce First Quarter 2026 Financial Results on May 4th April 6, 2026 4:00 PM - BizWire Form 4 VERTEX PHARMACEUTICALS For: Apr 01 Filed by: Liu Joy April 3, 2026 4:54 PM - SEC Filing Form ARS VERTEX PHARMACEUTICALS For: Dec 31 April 2, 2026 4:08 PM - SEC Filing Form DEFA14A VERTEX PHARMACEUTICALS April 2, 2026 4:06 PM - SEC Filing Form DEF 14A VERTEX PHARMACEUTICALS For: May 13 April 2, 2026 4:03 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Liu Joy April 1, 2026 1:02 PM - SEC Filing Vertex gets FDA approval to expand ALYFTREK and TRIKAFTA to 95% of US CF patients April 1, 2026 7:31 AM - StreetInsider Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States April 1, 2026 7:30 AM - BizWire Form 4 VERTEX PHARMACEUTICALS For: Mar 27 Filed by: Bozic Carmen March 31, 2026 4:11 PM - SEC Filing Form 8-K VERTEX PHARMACEUTICALS For: Mar 31 March 31, 2026 4:04 PM - SEC Filing BMO Capital on Vertex (VRTX): 'Ivacaftor Related Label Updates Unlikely to Impact CF Franchise Strength' March 30, 2026 8:26 AM - StreetInsider BMO Capital on Vertex (VRTX): label updates weigh on shares, but risk is limited March 27, 2026 3:37 PM - StreetInsider Form SCHEDULE 13G/A VERTEX PHARMACEUTICALS Filed by: VANGUARD GROUP INC March 27, 2026 1:55 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen March 27, 2026 10:32 AM - SEC Filing New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST March 21, 2026 1:55 PM - StreetInsider RBC Capital on Vertex (VRTX): 'Recent Weakness Creates Buying Opportunity' March 19, 2026 8:55 AM - StreetInsider Vertex (VRTX) PT Raised to $520 at Argus March 19, 2026 5:27 AM - StreetInsider RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns' March 18, 2026 9:21 AM - StreetInsider Maxim Group Upgrades Vertex (VRTX) to Buy March 18, 2026 7:59 AM - StreetInsider Form 4 VERTEX PHARMACEUTICALS For: Mar 13 Filed by: Bozic Carmen March 17, 2026 4:06 PM - SEC Filing Form 4 VERTEX PHARMACEUTICALS For: Mar 11 Filed by: McKechnie Duncan March 13, 2026 4:12 PM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: Bozic Carmen March 13, 2026 11:38 AM - SEC Filing Form 144 VERTEX PHARMACEUTICALS Filed by: McKechnie Duncan March 11, 2026 9:45 AM - SEC Filing Vertex (VRTX) PT Raised to $525 at Truist Securities March 10, 2026 9:51 AM - StreetInsider Stifel Reiterates Hold Rating on Vertex (VRTX) March 10, 2026 9:33 AM - StreetInsider Vertex (VRTX) PT Raised to $596 at Morgan Stanley March 10, 2026 8:47 AM - StreetInsider Vertex (VRTX) PT Raised to $641 at H.C. Wainwright March 10, 2026 8:27 AM - StreetInsider Bernstein: 'We continue to recommend Vertex (VRTX) and see no reason to take profits' March 10, 2026 8:02 AM - StreetInsider Jefferies Starts Vertex (VRTX) at Buy March 10, 2026 5:37 AM - StreetInsider Jefferies Starts Gilead Sciences (GILD) at Buy March 10, 2026 5:37 AM - StreetInsider Jefferies Starts Amgen (AMGN) at Hold March 10, 2026 5:37 AM - StreetInsider Vertex (VRTX) PT Raised to $600 at Oppenheimer March 10, 2026 5:09 AM - StreetInsider Vertex (VRTX) PT Raised to $585 at Citi March 10, 2026 4:56 AM - StreetInsider Wolfe Research Reiterates Outperform Rating on Vertex (VRTX) following Ph3 March 9, 2026 5:35 PM - StreetInsider BMO Capital Reiterates Outperform Rating on Vertex (VRTX) amid interim RAINIER data March 9, 2026 5:07 PM - StreetInsider After-hours movers: Hewlett Packard Enterprise, Yext, Vertex Pharma March 9, 2026 4:44 PM - StreetInsider Vertex reports positive phase 3 results for IgA nephropathy drug March 9, 2026 4:02 PM - StreetInsider Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy March 9, 2026 4:02 PM - BizWire Full Article List